Logo image of TELA

TELA BIO INC (TELA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:TELA - US8723811084 - Common Stock

1.14 USD
-0.01 (-0.87%)
Last: 12/4/2025, 8:00:00 PM
Fundamental Rating

3

TELA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. TELA may be in some trouble as it scores bad on both profitability and health. TELA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

TELA had negative earnings in the past year.
In the past year TELA has reported a negative cash flow from operations.
TELA had negative earnings in each of the past 5 years.
In the past 5 years TELA always reported negative operating cash flow.
TELA Yearly Net Income VS EBIT VS OCF VS FCFTELA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

TELA has a worse Return On Assets (-59.81%) than 69.15% of its industry peers.
With a Return On Equity value of -439.84%, TELA is not doing good in the industry: 80.85% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -59.81%
ROE -439.84%
ROIC N/A
ROA(3y)-56.26%
ROA(5y)-51.06%
ROE(3y)-229.9%
ROE(5y)-182.8%
ROIC(3y)N/A
ROIC(5y)N/A
TELA Yearly ROA, ROE, ROICTELA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800

1.3 Margins

TELA has a better Gross Margin (67.30%) than 71.28% of its industry peers.
TELA's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for TELA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.66%
GM growth 5Y2.26%
TELA Yearly Profit, Operating, Gross MarginsTELA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

3

2. Health

2.1 Basic Checks

TELA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TELA has more shares outstanding
Compared to 5 years ago, TELA has more shares outstanding
The debt/assets ratio for TELA has been reduced compared to a year ago.
TELA Yearly Shares OutstandingTELA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
TELA Yearly Total Debt VS Total AssetsTELA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -7.32, we must say that TELA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -7.32, TELA is doing worse than 72.87% of the companies in the same industry.
A Debt/Equity ratio of 4.14 is on the high side and indicates that TELA has dependencies on debt financing.
With a Debt to Equity ratio value of 4.14, TELA is not doing good in the industry: 85.64% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.14
Debt/FCF N/A
Altman-Z -7.32
ROIC/WACCN/A
WACC8.33%
TELA Yearly LT Debt VS Equity VS FCFTELA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

2.3 Liquidity

TELA has a Current Ratio of 3.19. This indicates that TELA is financially healthy and has no problem in meeting its short term obligations.
TELA's Current ratio of 3.19 is fine compared to the rest of the industry. TELA outperforms 60.11% of its industry peers.
A Quick Ratio of 2.59 indicates that TELA has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.59, TELA is in the better half of the industry, outperforming 61.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 2.59
TELA Yearly Current Assets VS Current LiabilitesTELA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 47.34% over the past year.
The Revenue has grown by 18.56% in the past year. This is quite good.
The Revenue has been growing by 35.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)47.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.76%
Revenue 1Y (TTM)18.56%
Revenue growth 3Y32.99%
Revenue growth 5Y35.01%
Sales Q2Q%9.14%

3.2 Future

Based on estimates for the next years, TELA will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.21% on average per year.
TELA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.05% yearly.
EPS Next Y39.17%
EPS Next 2Y27.3%
EPS Next 3Y23.96%
EPS Next 5Y18.21%
Revenue Next Year14.32%
Revenue Next 2Y18.11%
Revenue Next 3Y18.86%
Revenue Next 5Y14.05%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
TELA Yearly Revenue VS EstimatesTELA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
TELA Yearly EPS VS EstimatesTELA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -0.5 -1 -1.5 -2 -2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

TELA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TELA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TELA Price Earnings VS Forward Price EarningsTELA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TELA Per share dataTELA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as TELA's earnings are expected to grow with 23.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.3%
EPS Next 3Y23.96%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TELA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TELA BIO INC

NASDAQ:TELA (12/4/2025, 8:00:00 PM)

1.14

-0.01 (-0.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13 2025-11-13/amc
Earnings (Next)03-18 2026-03-18/amc
Inst Owners73.05%
Inst Owner Change0.73%
Ins Owners8.98%
Ins Owner Change2.36%
Market Cap49.90M
Revenue(TTM)69.30M
Net Income(TTM)-40.40M
Analysts81.82
Price Target4.74 (315.79%)
Short Float %1.04%
Short Ratio2.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-23.65%
Min EPS beat(2)-25.31%
Max EPS beat(2)-21.99%
EPS beat(4)0
Avg EPS beat(4)-12.58%
Min EPS beat(4)-25.31%
Max EPS beat(4)-1.21%
EPS beat(8)2
Avg EPS beat(8)-1.3%
EPS beat(12)4
Avg EPS beat(12)0.07%
EPS beat(16)4
Avg EPS beat(16)-4.28%
Revenue beat(2)1
Avg Revenue beat(2)0.17%
Min Revenue beat(2)-4.25%
Max Revenue beat(2)4.59%
Revenue beat(4)1
Avg Revenue beat(4)-6.6%
Min Revenue beat(4)-25.31%
Max Revenue beat(4)4.59%
Revenue beat(8)2
Avg Revenue beat(8)-6.05%
Revenue beat(12)3
Avg Revenue beat(12)-5.46%
Revenue beat(16)6
Avg Revenue beat(16)-3.81%
PT rev (1m)-13.89%
PT rev (3m)-13.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.42%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.66
P/FCF N/A
P/OCF N/A
P/B 5.43
P/tB 6.54
EV/EBITDA N/A
EPS(TTM)-0.89
EYN/A
EPS(NY)-0.53
Fwd EYN/A
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.78
OCFYN/A
SpS1.72
BVpS0.21
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -59.81%
ROE -439.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.3%
FCFM N/A
ROA(3y)-56.26%
ROA(5y)-51.06%
ROE(3y)-229.9%
ROE(5y)-182.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.66%
GM growth 5Y2.26%
F-Score4
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 4.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 50.05%
Cap/Sales 0.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.19
Quick Ratio 2.59
Altman-Z -7.32
F-Score4
WACC8.33%
ROIC/WACCN/A
Cap/Depr(3y)110.61%
Cap/Depr(5y)96.68%
Cap/Sales(3y)2.33%
Cap/Sales(5y)2.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.76%
EPS Next Y39.17%
EPS Next 2Y27.3%
EPS Next 3Y23.96%
EPS Next 5Y18.21%
Revenue 1Y (TTM)18.56%
Revenue growth 3Y32.99%
Revenue growth 5Y35.01%
Sales Q2Q%9.14%
Revenue Next Year14.32%
Revenue Next 2Y18.11%
Revenue Next 3Y18.86%
Revenue Next 5Y14.05%
EBIT growth 1Y20.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.3%
EBIT Next 3Y25.64%
EBIT Next 5Y23.27%
FCF growth 1Y19.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y17.47%
OCF growth 3YN/A
OCF growth 5YN/A

TELA BIO INC / TELA FAQ

Can you provide the ChartMill fundamental rating for TELA BIO INC?

ChartMill assigns a fundamental rating of 3 / 10 to TELA.


What is the valuation status for TELA stock?

ChartMill assigns a valuation rating of 1 / 10 to TELA BIO INC (TELA). This can be considered as Overvalued.


Can you provide the profitability details for TELA BIO INC?

TELA BIO INC (TELA) has a profitability rating of 1 / 10.


How financially healthy is TELA BIO INC?

The financial health rating of TELA BIO INC (TELA) is 3 / 10.


Can you provide the expected EPS growth for TELA stock?

The Earnings per Share (EPS) of TELA BIO INC (TELA) is expected to grow by 39.17% in the next year.